BioMedicine-Taiwan

Scope & Guideline

Innovating healthcare through open-access research.

Introduction

Delve into the academic richness of BioMedicine-Taiwan with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2211-8020
PublisherDIGITAL COMMONS BEPRESS
Support Open AccessYes
CountryTaiwan
TypeJournal
Convergefrom 2011 to 2024
AbbreviationBIOMEDICINE-TAIWAN / BioMedicine-Taiwan
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2100 MILVIA ST, STE 300, BERKELEY, CA 94704

Aims and Scopes

BioMedicine-Taiwan is a journal dedicated to advancing the field of biomedicine through the publication of high-quality research that spans a wide range of topics within this domain. The journal emphasizes translational research and the integration of clinical and laboratory findings, aiming to promote better understanding and treatment of diseases.
  1. Translational Medicine:
    The journal focuses on bridging the gap between laboratory research and clinical applications, promoting studies that translate basic scientific discoveries into practical medical solutions.
  2. Pharmacology and Toxicology:
    Research on drug effects, mechanisms of action, and toxicological evaluations of both synthetic and natural compounds is a core area, highlighting the safety and efficacy of various treatments.
  3. Molecular and Cellular Biology:
    Papers often explore molecular mechanisms underlying diseases, including studies on gene expression, protein function, and cellular signaling pathways.
  4. Public Health and Epidemiology:
    The journal publishes research that assesses disease prevalence, risk factors, and public health interventions, particularly in the context of emerging health threats like COVID-19.
  5. Innovative Therapeutic Approaches:
    There is a consistent emphasis on new therapeutic strategies, including the use of natural products, novel drug formulations, and advanced treatment methodologies.
BioMedicine-Taiwan is witnessing an evolution in its research focus, with several emerging trends that align with current health challenges and scientific advancements. These themes reflect the journal’s responsiveness to contemporary biomedical issues.
  1. Impact of COVID-19:
    There is a notable increase in publications related to COVID-19, exploring its effects on various health conditions, vaccine efficacy, and long-term health implications.
  2. Precision Medicine:
    Emerging themes in precision medicine, including personalized treatment approaches based on genetic and molecular profiling, are gaining traction, reflecting a shift towards more individualized healthcare.
  3. Neuroscience and Mental Health:
    Research on the neurobiological basis of mental health disorders and the effects of treatments on brain function is increasingly prominent, highlighting the growing recognition of mental health in biomedical research.
  4. Biomarkers and Predictive Medicine:
    The identification and validation of biomarkers for disease prediction and prognosis are trending, with studies focusing on their utility in clinical settings.
  5. Natural Products and Phytochemistry:
    An uptick in research on bioactive compounds from natural sources indicates a resurgence in interest in alternative therapies and their mechanisms of action.

Declining or Waning

While BioMedicine-Taiwan has a broad and dynamic focus, certain themes appear to be losing prominence based on recent publications. These waning scopes may reflect shifts in research priorities or advancements in understanding that render previous topics less central.
  1. Traditional Herbal Medicine:
    Research focusing on traditional herbal remedies has seen a decline, possibly due to a shift towards more scientifically validated and standardized therapeutic approaches.
  2. Basic Animal Studies:
    While animal studies remain critical, there appears to be a decrease in purely basic animal research as the journal prioritizes studies with direct clinical implications.
  3. General Reviews on Established Diseases:
    The frequency of general literature reviews on well-established diseases may be decreasing, as the journal favors original research and novel insights over summarization of existing knowledge.

Similar Journals

American Journal of Translational Research

Advancing the Frontiers of Translational Science
Publisher: E-CENTURY PUBLISHING CORPISSN: 1943-8141Frequency: 12 issues/year

The American Journal of Translational Research is a pivotal publication in the fields of Biochemistry, Genetics, and Molecular Biology, dedicated to advancing the understanding of translational science and its applications in clinical settings. Published by E-CENTURY PUBLISHING CORP, this journal, under ISSN 1943-8141, fosters scholarly exchange by publishing original research articles, reviews, and clinical studies that bridge the gap between laboratory discoveries and actual medical practice. Although its coverage in Scopus has been discontinued, the journal has previously held respectable rankings, including a 64th percentile in Clinical Biochemistry and 52nd in both Molecular Medicine and Cancer Research, indicating its influence and relevance in the scientific community. With its formal objective of disseminating significant findings that inform clinical practices, the journal remains a valuable resource for researchers, healthcare professionals, and students eager to stay at the forefront of translational research advancements.

Protein & Cell

Fostering Global Knowledge Exchange in Biochemical Research
Publisher: OXFORD UNIV PRESSISSN: 1674-800XFrequency: 12 issues/year

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

Experimental and Therapeutic Medicine

Unveiling the future of healthcare through innovative research.
Publisher: SPANDIDOS PUBL LTDISSN: 1792-0981Frequency: 12 issues/year

Experimental and Therapeutic Medicine is a distinguished peer-reviewed journal published by SPANDIDOS PUBL LTD, focusing on the dynamic fields of Immunology, Microbiology, and Cancer Research. With its ISSN 1792-0981 and E-ISSN 1792-1015, this journal holds a notable position in the research community, contributing valuable insights into experimental methodologies and therapeutic strategies that advance understanding in these critical areas. Although the journal's coverage in Scopus was discontinued after 2018, it continues to serve as a resource for emerging studies and novel discoveries, evidenced by its ranking within the 37th percentile in Immunology and Microbiology, and the 17th percentile in Cancer Research. Researchers, professionals, and students alike can benefit from its rigorous articles and comprehensive reviews, further enhancing their comprehension of the vibrant landscape of modern medicine. Explore this journal to discover pivotal findings that shape the future of healthcare.

New Armenian Medical Journal

Bridging Local Expertise with Global Health Challenges.
Publisher: YEREVAN STATE MEDICAL UNIVISSN: 1829-0825Frequency: 4 issues/year

New Armenian Medical Journal (ISSN: 1829-0825, E-ISSN: 1829-0825) is a prominent academic publication established by Yerevan State Medical University, dedicated to advancing the field of medicine through high-quality research and scholarly discourse. Located in Armenia, this journal serves as a vital platform for disseminating innovative findings and clinical practices, with a particular focus on the regional healthcare landscape as well as global health issues. While currently categorized in the lower quartile (Q4) of general medicine, it demonstrates a commitment to improving its impact factor and ranking, evidenced by its ongoing publication from 2009 to 2024. The journal embraces a diverse scope that encompasses miscellaneous topics within medical research, catering to the needs of practitioners, researchers, and students alike. Though not an open-access journal, it offers valuable insights and knowledge that contribute meaningfully to the medical community. By participating in this scholarly dialogue, readers can enhance their understanding and foster advancements in the ever-evolving field of medicine.

CURRENT MOLECULAR MEDICINE

Advancing the Frontiers of Molecular Medicine
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1566-5240Frequency: 10 issues/year

CURRENT MOLECULAR MEDICINE is a pivotal journal fostering advancements in the interdisciplinary fields of molecular medicine, biochemistry, and genetics. Published by Bentham Science Publishers, this esteemed journal has been disseminating vital research findings since its inception in 2001 and is continuously dedicated to exploring the molecular basis of health and disease. With a focus on translational research, CURRENT MOLECULAR MEDICINE provides an invaluable platform for researchers, healthcare professionals, and students, making significant contributions to the understanding of molecular mechanisms and therapeutic strategies. With an ISSN of 1566-5240 and an E-ISSN of 1875-5666, the journal holds a commendable position within the scientific community, being ranked Q3 in Biochemistry and Molecular Biology and Q2 in Medicine (miscellaneous) as of 2023. This journal does not currently operate on an open access model but remains accessible through various institutional subscriptions. The multidisciplinary scope covering molecular biology to medicinal applications positions CURRENT MOLECULAR MEDICINE as an essential resource for those striving to meet the challenges of modern healthcare and biomedical research.

Cell Reports Methods

Transforming Research with Innovative Methodologies
Publisher: CELL PRESSISSN: 2667-2375Frequency: 12 issues/year

Cell Reports Methods is a cutting-edge journal published by CELL PRESS, focusing on innovative methodologies in the vast fields of biochemistry, genetics, biotechnology, and radiological sciences. Launched in 2021, it has rapidly ascended to attain a Q1 ranking across multiple disciplines in the latest 2023 metrics, reflecting its influential contribution to the scientific community. With an emphasis on practical and rigorous experimental approaches, this journal serves as a vital resource for researchers looking to advance their methodologies and collaborate on significant findings in their respective specialties. Despite not being an open-access publication, Cell Reports Methods ensures broad accessibility through institutional subscriptions, allowing researchers from various backgrounds to engage with high-quality scholarly work. The journal presents a unique platform for sharing insights from interdisciplinary methods that foster innovation and discovery, ultimately shaping the future of scientific research.

Indonesian Biomedical Journal

Exploring New Frontiers in Molecular Biology
Publisher: PRODIA EDUCATION & RESEARCH INSTISSN: 2355-9179Frequency: 3 issues/year

Indonesian Biomedical Journal, published by PRODIA EDUCATION & RESEARCH INST, serves as a vital platform for the dissemination of groundbreaking research in the fields of biochemistry, genetics, and molecular biology, as well as general medicine. Since its inception, this Open Access journal has made significant strides in enhancing accessibility to scientific knowledge, allowing researchers, professionals, and students to engage with high-quality studies without financial barriers. With an ISSN of 2355-9179 and a focus on emerging biomedical topics, the journal has established itself in the academic community, securing Q3 and Q4 rankings in its respective categories for 2023. The journal's commitment to maintaining a rigorous peer-review process ensures that only the most innovative and impactful research is published, fostering an environment that encourages collaborative learning and discovery. As it converges from 2017 to 2024, the Indonesian Biomedical Journal continues to be an essential resource for those involved in advancing biomedical sciences, particularly within the unique context of Indonesia and beyond.

Biomed Research International

Fostering innovation through collaborative biomedical research.
Publisher: HINDAWI LTDISSN: 2314-6133Frequency: 1 issue/year

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Elevating the Standards of Biochemical Research
Publisher: Cell Physiol Biochem Press GmbH & CoISSN: 1015-8987Frequency: 6 issues/year

Cellular Physiology and Biochemistry is a premier Open Access journal published by the prestigious Cell Physiol Biochem Press GmbH & Co, dedicated to advancing research in the fields of physiology, biochemistry, and molecular biology. Since its inception in 1987 and transitioning to an Open Access model in 2013, the journal has established itself as a vital resource for the dissemination of high-quality research and reviews, showcasing innovative methodologies and groundbreaking findings in cellular processes. With an impressive ranking in the 2023 Scopus category as Q2 in Physiology and a robust percentile of 61, Cellular Physiology and Biochemistry is committed to fostering academic dialogue among researchers, professionals, and students alike. This journal not only provides unrestricted access to its articles, but also promotes the global sharing of knowledge, which is essential for the advancement of our understanding in these vital scientific areas. The journal's editorial team is dedicated to ensuring the highest standards of academic rigor and relevance, making it an indispensable addition to the libraries of those engaged in the life sciences.

BIOSCIENCE REPORTS

Fostering Innovation in Biological Research
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.